Browsing byAuthorHuggett, G
Showing results 1 to 7 of 7
Issue Date | Title | Author(s) |
2024-05-17 | Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysis. | O'Leary, C; Greer, R; Huggett, G; Good, P; Gurgenci, T; Hardy, J |
2024-05-30 | Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
2023-10-14 | Exploring potential anti-inflammatory effects of medicinal cannabis. | Gurgenci, T; Kijanka, G; Greer, R; Huggett, G; Good, P; Moniruzzaman, M; Hardy, J |
2024-05-01 | Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
2023-06 | Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials. | Gurgenci, T; Hardy, J; Olson, R; Huggett, G; Foster, K; Good, P |
2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
2022-09-05 | Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer. | Olson, RE; Smith, A; Huggett, G; Good, P; Dudley, M; Hardy, J |